Gowlings Expertise

To remain competitive in today's global marketplace, those in the life sciences industry require experienced and multidisciplinary legal counsel to ensure compliance with regulatory demands and to protect and enforce intellectual property. Managing these and other issues, Gowlings' Life Sciences Industry Group draws on the expertise of leading professionals across a range of practice areas, creating customized cross-disciplinary teams that provide health, agricultural and industrial sector clients with comprehensive legal coverage.

Gowlings is active on BIOTECanada's Subsequent Entry Biologics Task Force and our professionals bring decades of experience on regulatory issues to our clients. Click here for a list of Gowlings Professionals.

Below are a series of downloads from within our regulatory expertise.

An Update on Subsequent Entry Biologics - April 2009
by Adrienne Blanchard
From an IP protection and regulatory perspective, Adrienne discusses Health Canada's second-released draft guidance document, and proposed changes to its guidances relating to the Patented Medicines (Notice of Compliance) Regulations and Data Protection Regulations.
Click here to download a presentation with an SEB Update.
Click here to download and SEB Update article from the 2009-2010 Life Sciences & Law Current Issues book.

Canada to Develop Regulatory Pathway for Biosimilars (May 2008)
by Adrienne Blanchard and Dr. Alan West

Canadian Biologics Overview
by John Norman, Ph.D.
An overview of key terms, Canada's regulatory bodies, marketing biologics and regulatory challenges

Gowlings' Relevant Practice Areas

Advertising, Marketing and Regulatory Affairs

Drug Pricing & Reimbursement

Life Sciences Industry Group

Intellectual Property Litigation

Patent Prosecution